4 European Projects Found
Searched on 125080 European Projects
FINISHED
Beta Cell Generation by Stem Cell-Derived Implants in Diabetes (BetaCellTherapy)
Start date: Dec 1, 2015, End date: Aug 31, 2020,
Despite improved treatment, diabetes remains a chronic disease with major health risks and heavy burden on patients and society. Serious forms are caused by depletion in pancreatic beta cells and associated loss in insulin’s homeostatic control throughout life. Their cure requires restoration of a metabolically adequate beta cell mass. Implants of beta cell grafts prepared from human pancreases ha ...
Read Project
8
Partners Participants
FINISHED
Beta Cell Therapy in Diabetes (BETACELLTHERAPY)
Start date: Jan 1, 2010, End date: Jun 30, 2015,
Type 1 diabetes is a serious chronic disease with major health risks and heavy burden on patients and society. It is caused by massive immune-mediated loss of insulin-producing beta cells in the pancreas that can so far not be locally corrected. A cellular allotransplant in the liver can install a new beta cell mass but the size is insufficient and the procedure faces limitations of donor shortage ...
Read Project
18
Partners Participants
FINISHED
European Consortium for Communicating Stem Cell Research (EuroStemCell)
Start date: Mar 1, 2010, End date: Feb 28, 2015,
The European Consortium for Communicating Stem Cell Research, EUROSTEMCELL, brings together the major current FP6 and FP7 stem cell projects, the European Clinical Research Infrastructure Network, and four internationally recognized European stem cell centres to develop a comprehensive, coordinated platform for collation, dissemination and archiving of information on stem cell biology and regenera ...
Read Project
11
Partners Participants
FINISHED
Corline Heparin Technology - Enabling Regenerative Medicine (Corline)
Start date: Apr 1, 2011, End date: Sep 30, 2013,
Regenerative Medicine (use of cells and tissue to replace or heal impaired functions in the body, RM) is one of the fastest growing areas in today’s medicine, and has the potential to offer treatment to patients with diseases that are currently untreatable. In many new areas of RM there is however a need to improve the outcome of RM concepts and technologies for it to become a viable option to tra ...
Read Project
